Erratum: Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association (Circulation (2015) 132 (1435-1486) DOI: 10.1161/CIR.0000000000000296);Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association

Circulation

Volumn 132, Issue 15, 2015, Pages 1435-1486

  Baddour, Larry M ^a   Wilson, Walter R ^a   Bayer, Arnold S ^a   Fowler, Vance G ^a   Tleyjeh, Imad M ^a   Rybak, Michael J ^a   Barsic, Bruno ^a   Lockhart, Peter B ^a   Gewitz, Michael H ^a   Levison, Matthew E ^a   Bolger, Ann F ^a   Steckelberg, James M ^a   Baltimore, Robert S ^a   Fink, Anne M ^a   O'Gara, Patrick ^a   Taubert, Kathryn A ^a  

^a NONE

Author keywords

AHA Scientific Statements; anti infective agents; echocardiography; endocarditis; infection

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BACTERICIDE; BETA LACTAM; CEFAZOLIN; CEFTAROLINE; CEFTRIAXONE; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DAPTOMYCIN; GENTAMICIN; LINEZOLID; NAFCILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; RIFAMPICIN; STREPTOMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABIOTROPHIA DEFECTIVA; ADD ON THERAPY; ADJUVANT THERAPY; AGGREGATIBACTER; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTIFICIAL EMBOLISM; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; BLEEDING; BLOOD CULTURE; CARDIOBACTERIUM HOMINIS; CEREBROVASCULAR ACCIDENT; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DENTAL PROCEDURE; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG PENETRATION; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; EIKENELLA CORRODENS; EMBOLISM; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; EVIDENCE BASED PRACTICE; EXTRACRANIAL MYCOTIC ANEURYSM; FOLLOW UP; FUNGAL ENDOCARDITIS; GRAM NEGATIVE BACTERIUM; GRANULICATELLA; HAEMOPHILUS; HEALTH CARE PERSONNEL; HEART VALVE PROSTHESIS; HEART VALVE SURGERY; HUMAN; INTRACRANIAL ANEURYSM; INTRACRANIAL MYCOTIC ANEURYSM; KINGELLA; LONG TERM CARE; MEDICAL SOCIETY; METASTATIC FOCI OF INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS INFECTIVE ENDOCARDITIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYCOTIC ANEURYSM; OUTPATIENT CARE; PENICILLIN RESISTANCE; PERIANNULAR INFECTION; PEROPERATIVE CARE; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROSTHESIS MATERIAL; PROSTHETIC VALVE INFECTIVE ENDOCARDITIS; REVIEW; RIGHT SIDED INFECTIVE ENDOCARDITIS; SHORT COURSE THERAPY; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GALLOLYTICUS; STREPTOCOCCUS GROUP G; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT DURATION; VEIN PUNCTURE; ADULT; ADVERSE EFFECTS; BACTEREMIA; CANDIDIASIS; CARDIOVASCULAR SYSTEM EXAMINATION; COMPLICATION; ENDOCARDITIS; MICROBIOLOGY; PRACTICE GUIDELINE; PROSTHESIS-RELATED INFECTIONS; RHEUMATIC HEART DISEASE; RISK FACTOR; STANDARDS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS;

ADULT; ANTI-INFECTIVE AGENTS; ANTICOAGULANTS; BACTEREMIA; CANDIDIASIS; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; ENDOCARDITIS; HEART VALVE PROSTHESIS; HUMANS; PROSTHESIS-RELATED INFECTIONS; RHEUMATIC HEART DISEASE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS;

EID: 84944054071     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000332     Document Type: Erratum

References (327)

1. Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, Doco-Lecompte T, Celard M, Poyart C, Strady C, Chirouze C, Bes M, Cambau E, Iung B, Selton-Suty C, Hoen B, AEPEI Study Group Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol 2012 59 1968 1976. doi: 10.1016/j.jacc.2012.02.029
2. Correa de Sa DD, Tleyjeh IM, Anavekar NS, Schultz JC, Thomas JM, Lahr BD, Bachuwar A, Pazdernik M, Steckelberg JM, Wilson WR, Baddour LM, Epidemiological trends of infective endocarditis: A population-based study in Olmsted County, Minnesota [published correction appears in Mayo Clin Proc. 2010;85:772]. Mayo Clin Proc 2010 85 422 426
3. Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr, Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. Arch Intern Med 2012 172 363 365. doi: 10.1001/archinternmed.2011.1027
4. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Laden F, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Levinson D, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mock C, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leòn FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiebe N, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, AlMazroa MA, Memish ZA, Disability-Adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381:628]. Lancet 2012 380 2197 2223. doi: 10.1016/S0140-6736(12)61689-4
5. Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, Wilson WR, Baddour LM, A systematic review of population-based studies of infective endocarditis. Chest 2007 132 1025 1035. doi: 10.1378/chest.06-2048
6. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS, ICE Investigators Staphylococcus aureus endocarditis: A consequence of medical progress [published correction appears in JAMA. 2005;294:900]. JAMA 2005 293 3012 3021. doi: 10.1001/jama.293.24.3012
7. Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen B, AEPEI Study Group Preeminence of Staphylococcus aureus in infective endocarditis: A 1-year population-based survey. Clin Infect Dis 2012 54 1230 1239. doi: 10.1093/cid/cis199
8. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH, International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009 169 463 473. doi: 10.1001/archinternmed.2008.603
9. Benito N, Miró JM, de Lazzari E, Cabell CH, del Río A, Altclas J, Commerford P, Delahaye F, Dragulescu S, Giamarellou H, Habib G, Kamarulzaman A, Kumar AS, Nacinovich FM, Suter F, Tribouilloy C, Venugopal K, Moreno A, Fowler VG Jr, ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) Investigators Health care-Associated native valve endocarditis: importance of non-nosocomial acquisition [published correction appears in Ann Intern Med. 2010;152:480]. Ann Intern Med 2009 150 586 594. doi: 10.7326/0003-4819-150-9-200905050-00004
10. Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr, Corey GR, Chu VH, Fenely M, Pachirat O, Tan RS, Watkin R, Ionac A, Moreno A, Mestres CA, Casabé J, Chipigina N, Eisen DP, Spelman D, Delahaye F, Peterson G, Olaison L, Wang A, International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation 2010 121 1005 1013. doi: 10.1161/CIRCULATIONAHA.109.864488
11. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A, Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA 2011 306 2239 2247. doi: 10.1001/jama.2011.1701
12. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA, Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association [published correction appears in Circulation. 2007;115:e408; Circulation. 2007;116:e547; Circulation. 2005;112:2373; Circulation. 2008;118:e497]. Circulation 2005 111 e394 e434. doi: 10.1161/CIRCULATIONAHA.105.165564
13. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE, S aureus Endocarditis and Bacteremia Study Group Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006 355 653 665. doi: 10.1056/NEJMoa053783
14. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS, Enders F, Moustafa S, Mookadam F, Huskins WC, Wilson WR, Baddour LM, The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation 2007 115 1721 1728. doi: 10.1161/CIRCULATIONAHA.106.658831
15. Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, Tattevin P, Iung B, Delahaye F, Alla F, AEPEI Study Group The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J 2011 32 2003 2015. doi: 10.1093/eurheartj/ehp008
16. Sy RW, Bannon PG, Bayfield MS, Brown C, Kritharides L, Survivor treatment selection bias and outcomes research: A case study of surgery in infective endocarditis. Circ Cardiovasc Qual Outcomes 2009 2 469 474. doi: 10.1161/CIRCOUTCOMES.109.857938
17. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW, Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 2012 366 2466 2473. doi: 10.1056/NEJMoa1112843
18. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL, ESC Committee for Practice Guidelines Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC): endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009 30 2369 2413. doi: 10.1093/eurheartj/ehp285
19. Gould FK, Denning DW, Elliott TS, Foweraker J, Perry JD, Prendergast BD, Sandoe JA, Spry MJ, Watkin RW, Working Party of the British Society for Antimicrobial Chemotherapy Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: A report of the Working Party of the British Society for Antimicrobial Chemotherapy [published correction appears. J Antimicrob Chemother 2012 67 269 289. doi: 10.1093/jac/dkr450
20. Baltimore RS, Gewitz M, Baddour LM, Beerman LB, Jackson MA, Lockhart PB, Pahl E, Pike NA, Schutze GE, Shulman ST, Willoughby R Jr, on behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young and the Council on Cardiovascular and Stroke Nursing Infective endocarditis in childhood: 2015 update: A scientific statement from the American Heart Association [published online ahead of print September 14, 2015]. Circulation. doi: 10.1161/CIR.0000000000000298
21. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, Okum EJ, Wilson WR, Beerman LB, Bolger AF, Estes NA 3rd, Gewitz M, Newburger JW, Schron EB, Taubert KA, on behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; and Interdisciplinary Council on Quality of Care Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association. Circulation 2010 121 458 477. doi: 10.1161/CIRCULATIONAHA.109.192665
22. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA, Gewitz MH, Jacobs AK, Levison ME, Newburger JW, Pallasch TJ, Wilson WR, Baltimore RS, Falace DA, Shulman ST, Tani LY, Taubert KA, AHA Nonvalvular cardiovascular device-related infections. Circulation 2003 108 2015 2031. doi: 10.1161/01.CIR.0000093201.57771.47
23. Durack DT, Lukes AS, Bright DK, New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings: Duke Endocarditis Service. Am J Med 1994 96 200 209
24. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR, Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000 30 633 638. doi: 10.1086/313753
25. Bayer AS, Lam K, Ginzton L, Norman DC, Chiu CY, Ward JI, Staphylococcus aureus bacteremia: clinical, serologic, and echocardiographic findings in patients with and without endocarditis. Arch Intern Med 1987 147 457 462
26. Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, Cheng AC, Dudley T, Oddone EZ, Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003 163 2066 2072. doi: 10.1001/archinte.163.17.2066
27. Bayer AS, Ward JI, Ginzton LE, Shapiro SM, Evaluation of new clinical criteria for the diagnosis of infective endocarditis. Am J Med 1994 96 211 219
28. Hoen B, Selton-Suty C, Danchin N, Weber M, Villemot JP, Mathieu P, Floquet J, Canton P, Evaluation of the Duke criteria versus the Beth Israel criteria for the diagnosis of infective endocarditis. Clin Infect Dis 1995 21 905 909
29. Dodds GA, Sexton DJ, Durack DT, Bashore TM, Corey GR, Kisslo J, Negative predictive value of the Duke criteria for infective endocarditis. Am J Cardiol 1996 77 403 407
30. Arguello EA, Varini S, Romorini A, Elizari A, Clara L, Casabe H, Infective endocarditis in the Argentine Republic [abstract 152]. Paper presented at: Third International Symposium on Modern Concepts in Endocarditis July 13-15, 1995; Boston, MA
31. Kanavos K, Antoniadou A, Venetis C, Gezerlis P, Giamarellou H, Retrospective analysis of Duke's criteria in 60 cases of infective endocarditis in Greece [abstract 138]. Paper presented at: Third International Symposium on Modern Concepts in Endocarditis July 13-15, 1995; Boston, MA
32. Del Pont JM, De Cicco LT, Vartalitis C, Ithurralde M, Gallo JP, Vargas F, Gianantonio CA, Quirós RE, Infective endocarditis in children: clinical analyses and evaluation of two diagnostic criteria. Pediatr Infect Dis J 1995 14 1079 1086
33. Gagliardi JP, Nettles RE, McCarty DE, Sanders LL, Corey GR, Sexton DJ, Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria and the Duke Endocarditis Database. Clin Infect Dis 1998 26 1165 1168
34. Heiro M, Nikoskelainen J, Hartiala JJ, Saraste MK, Kotilainen PM, Diagnosis of infective endocarditis: sensitivity of the Duke vs von Reyn criteria. Arch Intern Med 1998 158 18 24
35. Nettles RE, McCarty DE, Corey GR, Li J, Sexton DJ, An evaluation of the Duke criteria in 25 pathologically confirmed cases of prosthetic valve endocarditis. Clin Infect Dis 1997 25 1401 1403
36. Stockheim JA, Chadwick EG, Kessler S, Amer M, Abdel-Haq N, Dajani AS, Shulman ST, Are the Duke criteria superior to the Beth Israel criteria for the diagnosis of infective endocarditis in children? Clin Infect Dis 1998 27 1451 1456
37. Hoen B, Béguinot I, Rabaud C, Jaussaud R, Selton-Suty C, May T, Canton P, The Duke criteria for diagnosing infective endocarditis are specific: Analysis of 100 patients with acute fever or fever of unknown origin. Clin Infect Dis 1996 23 298 302
38. Sekeres MA, Abrutyn E, Berlin JA, Kaye D, Kinman JL, Korzeniowski OM, Levison ME, Feldman RS, Strom BL, An assessment of the usefulness of the Duke criteria for diagnosing active infective endocarditis. Clin Infect Dis 1997 24 1185 1190
39. Fowler VG Jr, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J, Ryan T, Sexton DJ, Roussakis G, Harrell LJ, Corey GR, Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 1999 28 106 114. doi: 10.1086/515076
40. Fournier PE, Casalta JP, Habib G, Messana T, Raoult D, Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med 1996 100 629 633
41. Raoult D, Fournier PE, Drancourt M, Marrie TJ, Etienne J, Cosserat J, Cacoub P, Poinsignon Y, Leclercq P, Sefton AM, Diagnosis of 22 new cases of Bartonella endocarditis [published correction appears in Ann Intern Med. 1997;127:249]. Ann Intern Med 1996 125 646 652
42. Hamed KA, Dormitzer PR, Su CK, Relman DA, Haemophilus parainfluenzae endocarditis: Application of a molecular approach for identification of pathogenic bacterial species. Clin Infect Dis 1994 19 677 683
43. Podglajen I, Bellery F, Poyart C, Coudol P, Buu-Hoï A, Bruneval P, Mainardi JL, Comparative molecular and microbiologic diagnosis of bacterial endocarditis. Emerg Infect Dis 2003 9 1543 1547. doi: 10.3201/eid0912.030229
44. Goldenberger D, Künzli A, Vogt P, Zbinden R, Altwegg M, Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol 1997 35 2733 2739
45. Lamas CC, Eykyn SJ, Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: Analysis of 118 pathologically proven cases. Clin Infect Dis 1997 25 713 719
46. Berlin JA, Abrutyn E, Strom BL, Kinman JL, Levison ME, Korzeniowski OM, Feldman RS, Kaye D, Assessing diagnostic criteria for active infective endocarditis. Am J Cardiol 1994 73 887 891
47. Reynolds HR, Jagen MA, Tunick PA, Kronzon I, Sensitivity of transthoracic versus transesophageal echocardiography for the detection of native valve vegetations in the modern era. J Am Soc Echocardiogr 2003 16 67 70. doi: 10.1067/mje.2003.43
48. Daniel WG, Mügge A, Grote J, Hausmann D, Nikutta P, Laas J, Lichtlen PR, Martin RP, Comparison of transthoracic and transesophageal echocardiography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions. Am J Cardiol 1993 71 210 215
49. Heidenreich PA, Masoudi FA, Maini B, Chou TM, Foster E, Schiller NB, Owens DK, Echocardiography in patients with suspected endocarditis: A cost-effectiveness analysis. Am J Med 1999 107 198 208
50. Lindner JR, Case RA, Dent JM, Abbott RD, Scheld WM, Kaul S, Diagnostic value of echocardiography in suspected endocarditis: An evaluation based on the pretest probability of disease. Circulation 1996 93 730 736
51. Barton TL, Mottram PM, Stuart RL, Cameron JD, Moir S, Transthoracic echocardiography is still useful in the initial evaluation of patients with suspected infective endocarditis: evaluation of a large cohort at a tertiary referral center. Mayo Clin Proc 2014 89 799 805. doi: 10.1016/j.mayocp.2014.02.013
52. San Román JA, Vilacosta I, Zamorano JL, Almería C, Sánchez-Harguindey L, Transesophageal echocardiography in right-sided endocarditis. J Am Coll Cardiol 1993 21 1226 1230
53. Bayer AS, Infective endocarditis. Clin Infect Dis 1993 17 313 320; quiz 321
54. Daniel WG, Mügge A, Martin RP, Lindert O, Hausmann D, Nonnast-Daniel B, Laas J, Lichtlen PR, Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 1991 324 795 800. doi: 10.1056/NEJM199103213241203
55. Sanfilippo AJ, Picard MH, Newell JB, Rosas E, Davidoff R, Thomas JD, Weyman AE, Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol 1991 18 1191 1199
56. Rohmann S, Erbel R, Görge G, Makowski T, Mohr-Kahaly S, Nixdorff U, Drexler M, Meyer J, Clinical relevance of vegetation localization by transoesophageal echocardiography in infective endocarditis. Eur Heart J 1992 13 446 452. doi: http://dx.doi.org
57. Mügge A, Daniel WG, Frank G, Lichtlen PR, Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 1989 14 631 638. doi: 10.1016/0735-1097(89)90104-6
58. Steckelberg JM, Murphy JG, Ballard D, Bailey K, Tajik AJ, Taliercio CP, Giuliani ER, Wilson WR, Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991 114 635 640. doi: 10.7326/0003-4819-114-8-635
59. Erbel R, Rohmann S, Drexler M, Mohr-Kahaly S, Gerharz CD, Iversen S, Oelert H, Meyer J, Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach: A prospective study. Eur Heart J 1988 9 43 53
60. Rohmann S, Erbel R, Darius H, Görge G, Makowski T, Zotz R, Mohr-Kahaly S, Nixdorff U, Drexler M, Meyer J, Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr 1991 4 465 474
61. Sabik JF, Lytle BW, Blackstone EH, Marullo AG, Pettersson GB, Cosgrove DM, Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg 2002 74 650 659
62. Brecker SJ, Jin XY, Yacoub MH, Anatomical definition of aortic root abscesses by transesophageal echocardiography: planning a surgical strategy using homograft valves. Clin Cardiol 1995 18 353 359
63. Konstadt SN, Louie EK, Shore-Lesserson L, Black S, Scanlon P, The effects of loading changes on intraoperative Doppler assessment of mitral regurgitation. J Cardiothorac Vasc Anesth 1994 8 19 23
64. Hansalia S, Biswas M, Dutta R, Hage FG, Hsiung MC, Nanda NC, Singh P, Manda J, Kesanolla SK, Wei J, Yin WH, The value of live/real time three-dimensional transesophageal echocardiography in the assessment of valvular vegetations. Echocardiography 2009 26 1264 1273. doi: 10.1111/j.1540-8175.2009.01042.x
65. Liu YW, Tsai WC, Lin CC, Hsu CH, Li WT, Lin LJ, Chen JH, Usefulness of real-time three-dimensional echocardiography for diagnosis of infective endocarditis. Scand Cardiovasc J 2009 43 318 323. doi: 10.1080/14017430902737940
66. Fagman E, Perrotta S, Bech-Hanssen O, Flinck A, Lamm C, Olaison L, Svensson G, ECG-gated computed tomography: A new role for patients with suspected aortic prosthetic valve endocarditis. Eur Radiol 2012 22 2407 2414. doi: 10.1007/s00330-012-2491-5
67. Feuchtner GM, Stolzmann P, Dichtl W, Schertler T, Bonatti J, Scheffel H, Mueller S, Plass A, Mueller L, Bartel T, Wolf F, Alkadhi H, Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings. J Am Coll Cardiol 2009 53 436 444. doi: 10.1016/j.jacc.2008.01.077
68. Gahide G, Bommart S, Demaria R, Sportouch C, Dambia H, Albat B, Vernhet-Kovacsik H, Preoperative evaluation in aortic endocarditis: findings on cardiac CT. AJR Am J Roentgenol 2010 194 574 578. doi: 10.2214/AJR.08.2120
69. Duval X, Iung B, Klein I, Brochet E, Thabut G, Arnoult F, Lepage L, Laissy JP, Wolff M, Leport C, IMAGE (Resonance Magnetic Imaging at the Acute Phase of Endocarditis) Study Group Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: A prospective study. Ann Intern Med 2010 152 497 504, W175. doi: 10.7326/0003-4819-152-8-201004200-00006
70. Van Riet J, Hill EE, Gheysens O, Dymarkowski S, Herregods MC, Herijgers P, Peetermans WE, Mortelmans L, (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging 2010 37 1189 1197. doi: 10.1007/s00259-010-1380-x
71. Thuny F, Gaubert JY, Jacquier A, Tessonnier L, Cammilleri S, Raoult D, Habib G, Imaging investigations in infective endocarditis: current approach and perspectives. Arch Cardiovasc Dis 2013 106 52 62. doi: 10.1016/j.acvd.2012.09.004
72. Durack DT, Beeson PB, Experimental bacterial endocarditis, II: survival of a bacteria in endocardial vegetations. Br J Exp Pathol 1972 53 50 53
73. LaPlante KL, Rybak MJ, Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 2004 48 4665 4672. doi: 10.1128/AAC.48.12.4665-4672.2004
74. Arhin FF, Sarmiento I, Parr TR Jr, Moeck G, Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus. Int J Antimicrob Agents 2012 39 159 162. doi: 10.1016/j.ijantimicag.2011.09.017
75. Rose WE, Leonard SN, Rossi KL, Kaatz GW, Rybak MJ, Impact of inoculum size and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) on vancomycin activity and emergence of VISA in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 2009 53 805 807. doi: 10.1128/AAC.01009-08
76. Eagle H, The effect of the size of the inoculum and the age of the infection on the curative dose of penicillin in experimental infections with streptococci, pneumococci, and Treponema pallidum. J Exp Med 1949 90 595 607
77. Lunde CS, Rexer CH, Hartouni SR, Axt S, Benton BM, Fluorescence microscopy demonstrates enhanced targeting of telavancin to the division septum of Staphylococcus aureus. Antimicrob Agents Chemother 2010 54 2198 2200. doi: 10.1128/AAC.01609-09
78. Pogliano J, Pogliano N, Silverman JA, Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins. J Bacteriol 2012 194 4494 4504. doi: 10.1128/JB.00011-12
79. Eng RH, Padberg FT, Smith SM, Tan EN, Cherubin CE, Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother 1991 35 1824 1828
80. Stevens DL, Yan S, Bryant AE, Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: An explanation for the inoculum effect. J Infect Dis 1993 167 1401 1405
81. LaPlante KL, Woodmansee S, Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrob Agents Chemother 2009 53 3880 3886. doi: 10.1128/AAC.00134-09
82. Mizunaga S, Kamiyama T, Fukuda Y, Takahata M, Mitsuyama J, Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems. J Antimicrob Chemother 2005 56 91 96. doi: 10.1093/jac/dki163
83. Murray BE, Church DA, Wanger A, Zscheck K, Levison ME, Ingerman MJ, Abrutyn E, Mederski-Samoraj B, Comparison of two beta-lactamase-producing strains of Streptococcus faecalis. Antimicrob Agents Chemother 1986 30 861 864
84. Sabath LD, Garner C, Wilcox C, Finland M, Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins. Antimicrob Agents Chemother 1975 8 344 349
85. Johnson CC, Livornese L, Gold MJ, Pitsakis PG, Taylor S, Levison ME, Activity of cefepime against ceftazidime-resistant Gram-negative bacilli using low and high inocula. J Antimicrob Chemother 1995 35 765 773
86. Bayer AS, Hirano L, Yih J, Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis. Antimicrob Agents Chemother 1988 32 231 235
87. Ingerman M, Pitsakis PG, Rosenberg A, Hessen MT, Abrutyn E, Murray BE, Levison ME, Beta-lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis. J Infect Dis 1987 155 1226 1232
88. Jimenez-Lucho VE, Saravolatz LD, Medeiros AA, Pohlod D, Failure of therapy in pseudomonas endocarditis: selection of resistant mutants. J Infect Dis 1986 154 64 68
89. Hunter TH, Speculations on the mechanism of cure of bacterial endocarditis. J Am Med Assoc 1950 144 524 527
90. Francioli P, Ruch W, Stamboulian D, Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: A prospective multicenter study. Clin Infect Dis 1995 21 1406 1410
91. Chambers HF, Miller RT, Newman MD, Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med 1988 109 619 624
92. Ribera E, Gómez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez-Alujas T, Almirante B, Ocaña I, Pahissa A, Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis: A randomized, controlled trial. Ann Intern Med 1996 125 969 974
93. Bayer AS, Cheng D, Yeaman MR, Corey GR, McClelland RS, Harrel LJ, Fowler VG Jr, In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob Agents Chemother 1998 42 3169 3172
94. Carbon C, Crémieux AC, Fantin B, Pharmacokinetic and pharmacodynamic aspects of therapy of experimental endocarditis. Infect Dis Clin North Am 1993 7 37 51
95. Cremieux AC, Maziere B, Vallois JM, Ottaviani M, Azancot A, Raffoul H, Bouvet A, Pocidalo JJ, Carbon C, Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. J Infect Dis 1989 159 938 944
96. Crémieux AC, Mazière B, Vallois JM, Ottaviani M, Bouvet A, Pocidalo JJ, Carbon C, Ceftriaxone diffusion into cardiac fibrin vegetation: qualitative and quantitative evaluation by autoradiography. Fundam Clin Pharmacol 1991 5 53 60
97. Cremieux AC, Saleh-Mghir A, Vallois JM, Maziere B, Muffat-Joly M, Devine C, Bouvet A, Pocidalo JJ, Carbon C, Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations. Antimicrob Agents Chemother 1992 36 2216 2221
98. Fantin B, Leclercq R, Ottaviani M, Vallois JM, Maziere B, Duval J, Pocidalo JJ, Carbon C, In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis. Antimicrob Agents Chemother 1994 38 432 437
99. Mertes PM, Jehl F, Burtin P, Dopff C, Pinelli G, Villemot JP, Monteil H, Dureux JB, Penetration of ofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans. Antimicrob Agents Chemother 1992 36 2493 2496
100. Nicolau DP, Freeman CD, Nightingale CH, Coe CJ, Quintiliani R, Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1994 38 1515 1518
101. Rybak MJ, Pharmacodynamics: relation to antimicrobial resistance. Am J Med 2006 119 suppl 1 S37 S44. doi: 10.1016/j.amjmed.2006.04.001
102. Drusano GL, Antimicrobial pharmacodynamics: critical interactions of "bug and drug." Nat Rev Microbiol 2004 2 289 300. doi: 10.1038/nrmicro862
103. Craig WA, Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998 26 1 10; quiz 11 12
104. Forrest A, Nix DE, Ballow CH, Goss TF, Birmingham MC, Schentag JJ, Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 1993 37 1073 1081
105. Hughes DW, Frei CR, Maxwell PR, Green K, Patterson JE, Crawford GE, Lewis JS 2nd, Continuous versus intermittent infusion of oxacillin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 2009 53 2014 2019. doi: 10.1128/AAC.01232-08
106. Li J, Echevarria KL, Hughes DW, Cadena JA, Bowling JE, Lewis JS 2nd, Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 2014 58 5117 5124. doi: 10.1128/AAC.02800-14
107. Kashuba AD, Nafziger AN, Drusano GL, Bertino JS Jr, Optimizing aminoglycoside therapy for nosocomial pneumonia caused by Gram-negative bacteria. Antimicrob Agents Chemother 1999 43 623 629
108. Louie A, Kaw P, Liu W, Jumbe N, Miller MH, Drusano GL, Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection. Antimicrob Agents Chemother 2001 45 845 851. doi: 10.1128/AAC.45.3.845-851.2001
109. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak MJ, Talan DA, Chambers HF, Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011 52 285 292. doi: 10.1093/cid/cir034
110. Rose WE, Leonard SN, Sakoulas G, Kaatz GW, Zervos MJ, Sheth A, Carpenter CF, Rybak MJ, Daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 2008 52 831 836. doi: 10.1128/AAC.00869-07
111. Chambers HF, Basuino L, Diep BA, Steenbergen J, Zhang S, Tattevin P, Alder J, Relationship between susceptibility to daptomycin in vitro and activity in vivo in a rabbit model of aortic valve endocarditis. Antimicrob Agents Chemother 2009 53 1463 1467. doi: 10.1128/AAC.01307-08
112. Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, Dalovisio JR, Levine DP, Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists [published correction appears in Am J Health Syst Pharm. 2009;66:887]. Am J Health Syst Pharm 2009 66 82 98. doi: 10.2146/ajhp080434
113. Kullar R, Davis SL, Levine DP, Rybak MJ, Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin Infect Dis 2011 52 975 981. doi: 10.1093/cid/cir124
114. Bai AD, Showler A, Burry L, Steinberg M, Ricciuto DR, Fernandes T, Chiu A, Raybardhan S, Science M, Fernando E, Tomlinson G, Bell CM, Morris AM, Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis 2015 60 1451 1461. doi: 10.1093/cid/civ120
115. Yamamoto S, Hosokawa N, Sogi M, Inakaku M, Imoto K, Ohji G, Doi A, Iwabuchi S, Iwata K, Impact of infectious diseases service consultation on diagnosis of infective endocarditis. Scand J Infect Dis 2012 44 270 275. doi: 10.3109/00365548.2011.638317
116. Morris AJ, Drinković D, Pottumarthy S, MacCulloch D, Kerr AR, West T, Bacteriological outcome after valve surgery for active infective endocarditis: implications for duration of treatment after surgery. Clin Infect Dis 2005 41 187 194. doi: 10.1086/430908
117. Muñoz P, Giannella M, Scoti F, Predomingo M, Puga D, Pinto A, Roda J, Marin M, Bouza E, Group for the Management of Infective Endocarditis of the Gregorio Marañón Hospital (GAME) Two weeks of postsurgical therapy may be enough for high-risk cases of endocarditis caused by Streptococcus viridans or Streptococcus bovis. Clin Microbiol Infect 2012 18 293 299. doi: 10.1111/j.1469-0691.2011.03594.x
118. Francioli P, Etienne J, Hoigné R, Thys JP, Gerber A, Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks: efficacy and outpatient treatment feasibility. JAMA 1992 267 264 267
119. Wilson WR, Ceftriaxone sodium therapy of penicillin G-susceptible streptococcal endocarditis. JAMA 1992 267 279 280
120. Sexton DJ, Tenenbaum MJ, Wilson WR, Steckelberg JM, Tice AD, Gilbert D, Dismukes W, Drew RH, Durack DT, Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci: Endocarditis Treatment Consortium Group. Clin Infect Dis 1998 27 1470 1474
121. Francioli PB, Ceftriaxone and outpatient treatment of infective endocarditis. Infect Dis Clin North Am 1993 7 97 115
122. Bickford CL, Spencer AP, Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature. Pharmacotherapy 2005 25 1389 1395. doi: 10.1592/phco.2005.25.10.1389
123. Prabhu RM, Piper KE, Baddour LM, Steckelberg JM, Wilson WR, Patel R, Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002. Antimicrob Agents Chemother 2004 48 4463 4465. doi: 10.1128/AAC.48.11.4463-4465.2004
124. Knoll B, Tleyjeh IM, Steckelberg JM, Wilson WR, Baddour LM, Infective endocarditis due to penicillin-resistant viridans group streptococci. Clin Infect Dis 2007 44 1585 1592. doi: 10.1086/518174
125. Shelburne SA 3rd, Greenberg SB, Aslam S, Tweardy DJ, Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci. J Infect 2007 54 e99 e101. doi: 10.1016/j.jinf.2006.05.010
126. Fujitani S, Rowlinson MC, George WL, Penicillin G-resistant viridans group streptococcal endocarditis and interpretation of the American Heart Association's guidelines for the treatment of infective endocarditis. Clin Infect Dis 2008 46 1064 1066. doi: 10.1086/529199
127. Roberts R, Kaye D, Streptococcal endocarditis: the viridans and beta-hemolytic streptococci. Infective Endocarditis 1992 New York, NY Raven Press 191 208. In
128. Bouvet A, Cremieux AC, Contrepois A, Vallois JM, Lamesch C, Carbon C, Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci. Antimicrob Agents Chemother 1985 28 607 611
129. Lefort A, Mainardi JL, Selton-Suty C, Casassus P, Guillevin L, Lortholary O, Streptococcus pneumoniae endocarditis in adults: A multicenter study in France in the era of penicillin resistance (1991-1998): the Pneumococcal Endocarditis Study Group. Medicine (Baltimore) 2000 79 327 337
130. Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, Ko WC, Chedid MB, Andremont A, Klugman KP, International Pneumococcal Study Group An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003 37 230 237. doi: 10.1086/377534
131. Martínez E, Miró JM, Almirante B, Aguado JM, Fernandez-Viladrich P, Fernandez-Guerrero ML, Villanueva JL, Dronda F, Moreno-Torrico A, Montejo M, Llinares P, Gatell JM, Spanish Pneumococcal Endocarditis Study Group Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults. Clin Infect Dis 2002 35 130 139. doi: 10.1086/341024
132. Smyth EG, Pallett AP, Davidson RN, Group G streptococcal endocarditis: two case reports, a review of the literature and recommendations for treatment. J Infect 1988 16 169 176
133. Baddour LM, Infective endocarditis caused by beta-hemolytic streptococci: the Infectious Diseases Society of America's Emerging Infections Network. Clin Infect Dis 1998 26 66 71
134. Lefort A, Lortholary O, Casassus P, Selton-Suty C, Guillevin L, Mainardi JL, β-Hemolytic Streptococci Infective Endocarditis Study Group Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and G) and Streptococcus milleri: A multicenter study in France. Arch Intern Med 2002 162 2450 2456
135. Sambola A, Miro JM, Tornos MP, Almirante B, Moreno-Torrico A, Gurgui M, Martinez E, Del Rio A, Azqueta M, Marco F, Gatell JM, Streptococcus agalactiae infective endocarditis: Analysis of 30 cases and review of the literature, 1962-1998. Clin Infect Dis 2002 34 1576 1584. doi: 10.1086/340538
136. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Paré C, Almirante B, Muñoz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Jones SB, Casabé J, Morris A, Corey GR, Cabell CH, International Collaboration on Endocarditis-Prospective Cohort Study Investigators Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007 297 1354 1361. doi: 10.1001/jama.297.12.1354
137. Chu VH, Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA, Federspiel J, Athan E, Stryjewski ME, Nacinovich F, Marco F, Levine DP, Elliott TS, Fortes CQ, Tornos P, Gordon DL, Utili R, Delahaye F, Corey GR, Fowler VG Jr, International Collaboration on Endocarditis-Prospective Cohort Study Group Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 2008 46 232 242. doi: 10.1086/524666
138. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK, Vancomycin-Resistant Staphylococcus aureus Investigative Team Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003 348 1342 1347. doi: 10.1056/NEJMoa025025
139. Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC, Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis 2003 36 429 439. doi: 10.1086/346207
140. van Hal SJ, Lodise TP, Paterson DL, The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: A systematic review and meta-Analysis. Clin Infect Dis 2012 54 755 771. doi: 10.1093/cid/cir935
141. Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O'Sullivan MV, Anderson TL, Roberts SA, Gao W, Christiansen KJ, Coombs GW, Johnson PD, Howden BP, Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis 2011 204 340 347. doi: 10.1093/infdis/jir270
142. Cervera C, Castañeda X, de la Maria CG, del Rio A, Moreno A, Soy D, Pericas JM, Falces C, Armero Y, Almela M, Ninot S, Pare JC, Mestres CA, Gatell JM, Marco F, Miro JM, Hospital Clinic Endocarditis Study Group Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis. Clin Infect Dis 2014 58 1668 1675. doi: 10.1093/cid/ciu183
143. Anguera I, Del Río A, Miró JM, Matínez-Lacasa X, Marco F, Gumá JR, Quaglio G, Claramonte X, Moreno A, Mestres CA, Mauri E, Azqueta M, Benito N, García-de la María C, Almela M, Jiménez-Expósito MJ, Sued O, De Lazzari E, Gatell JM, Hospital Clinic Endocarditis Study Group Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart 2005 91 e10. doi: 10.1136/hrt.2004.040659
144. Liu PY, Huang YF, Tang CW, Chen YY, Hsieh KS, Ger LP, Chen YS, Liu YC, Staphylococcus lugdunensis infective endocarditis: A literature review and analysis of risk factors. J Microbiol Immunol Infect 2010 43 478 484. doi: 10.1016/S1684-1182(10)60074-6
145. Seenivasan MH, Yu VL, Staphylococcus lugdunensis endocarditis: the hidden peril of coagulase-negative staphylococcus in blood cultures. Eur J Clin Microbiol Infect Dis 2003 22 489 491. doi: 10.1007/s10096-003-0953-z
146. Pereira EM, Oliveira FL, Schuenck RP, Zoletti GO, Dos Santos KR, Detection of Staphylococcus lugdunensis by a new species-specific PCR based on the fbl gene. FEMS Immunol Med Microbiol 2010 58 295 298. doi: 10.1111/j.1574-695X.2009.00626.x
147. Pinsky BA, Samson D, Ghafghaichi L, Baron EJ, Banaei N, Comparison of real-time PCR and conventional biochemical methods for identification of Staphylococcus lugdunensis. J Clin Microbiol 2009 47 3472 3477. doi: 10.1128/JCM.00342-09
148. Fortún J, Navas E, Martínez-Beltrán J, Pérez-Molina J, Martín-Dávila P, Guerrero A, Moreno S, Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. Clin Infect Dis 2001 33 120 125. doi: 10.1086/320869
149. Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW, Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 2009 48 713 721. doi: 10.1086/597031
150. Heldman AW, Hartert TV, Ray SC, Daoud EG, Kowalski TE, Pompili VJ, Sisson SD, Tidmore WC, vom Eigen KA, Goodman SN, Lietman PS, Petty BG, Flexner C, Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 1996 101 68 76
151. Dworkin RJ, Lee BL, Sande MA, Chambers HF, Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet 1989 2 1071 1073
152. Murray HW, Wigley FM, Mann JJ, Arthur RR, Combination antibiotic therapy in staphylococcal endocarditis: the use of methicillin sodium-gentamicin sulfate therapy. Arch Intern Med 1976 136 480 483
153. McConeghy KW, Bleasdale SC, Rodvold KA, The empirical combination of vancomycin and a β-lactam for staphylococcal bacteremia. Clin Infect Dis 2013 57 1760 1765. doi: 10.1093/cid/cit560
154. Korzeniowski O, Sande MA, Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann Intern Med 1982 97 496 503
155. Dodek P, Phillips P, Questionable history of immediate-type hypersensitivity to penicillin in staphylococcal endocarditis: treatment based on skin-test results versus empirical alternative treatment: A decision analysis. Clin Infect Dis 1999 29 1251 1256. doi: 10.1086/313435
156. Nannini EC, Singh KV, Murray BE, Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue. Clin Infect Dis 2003 37 1194 1198. doi: 10.1086/379021
157. Watanakunakorn C, Clindamycin therapy of Staphylococcus aureus endocarditis: clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin. Am J Med 1976 60 419 425
158. Mortara LA, Bayer AS, Staphylococcus aureus bacteremia and endocarditis: new diagnostic and therapeutic concepts. Infect Dis Clin North Am 1993 7 53 68
159. Carugati M, Bayer AS, Miró JM, Park LP, Guimarães AC, Skoutelis A, Fortes CQ, Durante-Mangoni E, Hannan MM, Nacinovich F, Fernández-Hidalgo N, Grossi P, Tan RS, Holland T, Fowler VG Jr, Corey RG, Chu VH, International Collaboration on Endocarditis High-dose daptomycin therapy for left-sided infective endocarditis: A prospective study from the International Collaboration on Endocarditis. Antimicrob Agents Chemother 2013 57 6213 6222. doi: 10.1128/AAC.01563-13
160. Silverman JA, Mortin LI, Vanpraagh AD, Li T, Alder J, Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis 2005 191 2149 2152. doi: 10.1086/430352
161. Le T, Bayer AS, Combination antibiotic therapy for infective endocarditis. Clin Infect Dis 2003 36 615 621. doi: 10.1086/367661
162. Riedel DJ, Weekes E, Forrest GN, Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus. Antimicrob Agents Chemother 2008 52 2463 2467. doi: 10.1128/AAC.00300-08
163. Levine DP, Fromm BS, Reddy BR, Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991 115 674 680
164. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR, Infectious Diseases Society of America Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013 56 1 10. doi: 10.1093/cid/cis966
165. Markowitz N, Quinn EL, Saravolatz LD, Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992 117 390 398. doi: 10.7326/0003-4819-117-5-390
166. Proctor RA, Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008 46 584 593. doi: 10.1086/525536
167. Steed ME, Vidaillac C, Rybak MJ, Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations. Antimicrob Agents Chemother 2010 54 5187 5192. doi: 10.1128/AAC.00536-10
168. Dhand A, Bayer AS, Pogliano J, Yang SJ, Bolaris M, Nizet V, Wang G, Sakoulas G, Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Infect Dis 2011 53 158 163. doi: 10.1093/cid/cir340
169. Mehta S, Singh C, Plata KB, Chanda PK, Paul A, Riosa S, Rosato RR, Rosato AE, β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives. Antimicrob Agents Chemother 2012 56 6192 6200. doi: 10.1128/AAC.01525-12
170. Werth BJ, Sakoulas G, Rose WE, Pogliano J, Tewhey R, Rybak MJ, Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model [published correction appears .Antimicrob Agents Chemother 2013 57 66 73. doi: 10.1128/AAC.01586-12
171. Werth BJ, Vidaillac C, Murray KP, Newton KL, Sakoulas G, Nonejuie P, Pogliano J, Rybak MJ, Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA. Antimicrob Agents Chemother 2013 57 2376 2379. doi: 10.1128/AAC.02354-12
172. Jang HC, Kim SH, Kim KH, Kim CJ, Lee S, Song KH, Jeon JH, Park WB, Kim HB, Park SW, Kim NJ, Kim EC, Oh MD, Choe KW, Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis 2009 49 395 401. doi: 10.1086/600295
173. Tattevin P, Uhel F, Fily F, Observational studies of salvage treatment for persistent bacteremia: beware of survivor treatment selection bias. Clin Infect Dis 2009 49 1960; author reply 1961. doi: 10.1086/648500
174. Falagas ME, Manta KG, Ntziora F, Vardakas KZ, Linezolid for the treatment of patients with endocarditis: A systematic review of the published evidence. J Antimicrob Chemother 2006 58 273 280. doi: 10.1093/jac/dkl219
175. Schwalm JD, El-Helou P, Lee CH, Clinical outcome with oral linezolid and rifampin following recurrent methicillin-resistant Staphylococcus aureus bacteremia despite prolonged vancomycin treatment. Can J Infect Dis 2004 15 97 100
176. Muñoz P, Rodríguez-Creixéms M, Moreno M, Marín M, Ramallo V, Bouza E, GAME Study Group Linezolid therapy for infective endocarditis. Clin Microbiol Infect 2007 13 211 215. doi: 10.1111/j.1469-0691.2006.01585.x
177. Sander A, Beiderlinden M, Schmid EN, Peters J, Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci. Intensive Care Med 2002 28 1157 1160. doi: 10.1007/s00134-002-1358-7
178. Nace H, Lorber B, Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin. J Antimicrob Chemother 2010 65 1315 1316. doi: 10.1093/jac/dkq113
179. Ho TT, Cadena J, Childs LM, Gonzalez-Velez M, Lewis JS 2nd, Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy. J Antimicrob Chemother 2012 67 1267 1270. doi: 10.1093/jac/dks006
180. Lin JC, Aung G, Thomas A, Jahng M, Johns S, Fierer J, The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: A retrospective case series of 10 patients. J Infect Chemother 2013 19 42 49. doi: 10.1007/s10156-012-0449-9
181. Casapao AM, Davis SL, Barr VO, Klinker KP, Goff DA, Barber KE, Kaye KS, Mynatt RP, Molloy LM, Pogue JM, Rybak MJ, Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy. Antimicrob Agents Chemother 2014 58 2541 2546. doi: 10.1128/AAC.02371-13
182. Chu VH, Miro JM, Hoen B, Cabell CH, Pappas PA, Jones P, Stryjewski ME, Anguera I, Braun S, Muñoz P, Commerford P, Tornos P, Francis J, Oyonarte M, Selton-Suty C, Morris AJ, Habib G, Almirante B, Sexton DJ, Corey GR, Fowler VG Jr, International Collaboration on Endocarditis-Prospective Cohort Study Group Coagulase-negative staphylococcal prosthetic valve endocarditis: A contemporary update based on the International Collaboration on Endocarditis: prospective cohort study. Heart 2009 95 570 576. doi: 10.1136/hrt.2008.152975
183. Drinković D, Morris AJ, Pottumarthy S, MacCulloch D, West T, Bacteriological outcome of combination versus single-Agent treatment for staphylococcal endocarditis. J Antimicrob Chemother 2003 52 820 825. doi: 10.1093/jac/dkg440
184. Chuard C, Herrmann M, Vaudaux P, Waldvogel FA, Lew DP, Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother 1991 35 2611 2616
185. Lucet JC, Herrmann M, Rohner P, Auckenthaler R, Waldvogel FA, Lew DP, Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1990 34 2312 2317
186. John MD, Hibberd PL, Karchmer AW, Sleeper LA, Calderwood SB, Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infect Dis 1998 26 1302 1309
187. Wilson WR, Geraci JE, Antibiotic treatment of infective endocarditis. Annu Rev Med 1983 34 413 427
188. Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, Bisno AL, Ferrieri P, Shulman ST, Durack DT, Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms: American Heart Association. JAMA 1995 274 1706 1713
189. Olaison L, Schadewitz K, Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used? Clin Infect Dis 2002 34 159 166. doi: 10.1086/338233
190. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A, Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med 2007 146 574 579
191. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A, Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis. Clin Infect Dis 2013 56 1261 1268. doi: 10.1093/cid/cit052
192. Chirouze C, Athan E, Alla F, Chu VH, Ralph Corey G, Selton-Suty C, Erpelding ML, Miro JM, Olaison L, Hoen B, International Collaboration on Endocarditis Study Group Enterococcal endocarditis in the beginning of the 21st century: Analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. Clin Microbiol Infect 2013 19 1140 1147. doi: 10.1111/1469-0691.12166
193. Dahl A, Rasmussen RV, Bundgaard H, Hassager C, Bruun LE, Lauridsen TK, Moser C, Sogaard P, Arpi M, Bruun NE, Enterococcus faecalis infective endocarditis: A pilot study of the relationship between duration of gentamicin treatment and outcome. Circulation 2013 127 1810 1817. doi: 10.1161/CIRCULATIONAHA.112.001170
194. Geraci JE, The antibiotic therapy of bacterial endocarditis: therapeutic data on 172 patients seen from 1951 through 1957: Additional observations on short-term therapy (two weeks) for penicillin-sensitive streptococcal endocarditis. Med Clin North Am 1958 42 1101 1140
195. Miro JM, Pericas JM, del Rio A, Hospital Clinic Endocarditis Study Group A new era for treating Enterococcus faecalis endocarditis: Ampicillin plus short-course gentamicin or ampicillin plus ceftriaxone: that is the question! Circulation 2013 127 1763 1766. doi: 10.1161/CIRCULATIONAHA.113.002431
196. Wilson WR, Wilkowske CJ, Wright AJ, Sande MA, Geraci JE, Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med 1984 100 816 823
197. Mandell GL, Kaye D, Levison ME, Hook EW, Enterococcal endocarditis: An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med 1970 125 258 264
198. Brandt CM, Rouse MS, Laue NW, Stratton CW, Wilson WR, Steckelberg JM, Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-Active agents. J Infect Dis 1996 173 909 913
199. Gavaldà J, Torres C, Tenorio C, López P, Zaragoza M, Capdevila JA, Almirante B, Ruiz F, Borrell N, Gomis X, Pigrau C, Baquero F, Pahissa A, Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agents Chemother 1999 43 639 646
200. Arias CA, Contreras GA, Murray BE, Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect 2010 16 555 562. doi: 10.1111/j.1198-743X.2010.03214.x
201. Kainer MA, Devasia RA, Jones TF, Simmons BP, Melton K, Chow S, Broyles J, Moore KL, Craig AS, Schaffner W, Response to emerging infection leading to outbreak of linezolid-resistant enterococci. Emerg Infect Dis 2007 13 1024 1030. doi: 10.3201/eid1307.070019
202. Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ, Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis 2003 36 159 168. doi: 10.1086/345744
203. Mave V, Garcia-Diaz J, Islam T, Hasbun R, Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid? J Antimicrob Chemother 2009 64 175 180. doi: 10.1093/jac/dkp154
204. Babcock HM, Ritchie DJ, Christiansen E, Starlin R, Little R, Stanley S, Successful treatment of vancomycin-resistant enterococcus endocarditis with oral linezolid. Clin Infect Dis 2001 32 1373 1375. doi: 10.1086/319986
205. Wareham DW, Abbas H, Karcher AM, Das SS, Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid. J Infect 2006 52 300 304. doi: 10.1016/j.jinf.2005.05.022
206. Tsigrelis C, Singh KV, Coutinho TD, Murray BE, Baddour LM, Vancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors. J Clin Microbiol 2007 45 631 635. doi: 10.1128/JCM.02188-06
207. Hidron AI, Schuetz AN, Nolte FS, Gould CV, Osborn MK, Daptomycin resistance in Enterococcus faecalis prosthetic valve endocarditis. J Antimicrob Chemother 2008 61 1394 1396. doi: 10.1093/jac/dkn105
208. Levine DP, Lamp KC, Daptomycin in the treatment of patients with infective endocarditis: experience from a registry. Am J Med 2007 120 suppl 1 S28 S33. doi: 10.1016/j.amjmed.2007.07.011
209. Segreti JA, Crank CW, Finney MS, Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: A retrospective case series of 31 patients. Pharmacotherapy 2006 26 347 352. doi: 10.1592/phco.26.3.347
210. Kanafani ZA, Federspiel JJ, Fowler VG Jr, Infective endocarditis caused by daptomycin-resistant Enterococcus faecalis: A case report. Scand J Infect Dis 2007 39 75 77. doi: 10.1080/00365540600786465
211. Schutt AC, Bohm NM, Multidrug-resistant Enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin. Ann Pharmacother 2009 43 2108 2112. doi: 10.1345/aph.1M324
212. Casapao AM, Kullar R, Davis SL, Levine DP, Zhao JJ, Potoski BA, Goff DA, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ, Multicenter study of high-dose daptomycin for treatment of enterococcal infections. Antimicrob Agents Chemother 2013 57 4190 4196. doi: 10.1128/AAC.00526-13
213. Hall AD, Steed ME, Arias CA, Murray BE, Rybak MJ, Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 2012 56 3174 3180. doi: 10.1128/AAC.06439-11
214. Sakoulas G, Nonejuie P, Nizet V, Pogliano J, Crum-Cianflone N, Haddad F, Treatment of high-level gentamicin-resistant Enterococcus faecalis endocarditis with daptomycin plus ceftaroline. Antimicrob Agents Chemother 2013 57 4042 4045. doi: 10.1128/AAC.02481-12
215. Sakoulas G, Rose W, Nonejuie P, Olson J, Pogliano J, Humphries R, Nizet V, Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 2014 58 1494 1500. doi: 10.1128/AAC.02274-13
216. Sakoulas G, Bayer AS, Pogliano J, Tsuji BT, Yang SJ, Mishra NN, Nizet V, Yeaman MR, Moise PA, Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 2012 56 838 844. doi: 10.1128/AAC.05551-11
217. Kullar R, Casapao AM, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ, A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis. J Antimicrob Chemother 2013 68 2921 2926. doi: 10.1093/jac/dkt294
218. Geraci JE, Wilson WR, Symposium on infective endocarditis, III: endocarditis due to Gram-negative bacteria: report of 56 cases. Mayo Clin Proc 1982 57 145 148
219. Coburn B, Toye B, Rawte P, Jamieson FB, Farrell DJ, Patel SN, Antimicrobial susceptibilities of clinical isolates of HACEK organisms. Antimicrob Agents Chemother 2013 57 1989 1991. doi: 10.1128/AAC.00111-13
220. Chambers ST, Murdoch D, Morris A, Holland D, Pappas P, Almela M, Fernández-Hidalgo N, Almirante B, Bouza E, Forno D, del Rio A, Hannan MM, Harkness J, Kanafani ZA, Lalani T, Lang S, Raymond N, Read K, Vinogradova T, Woods CW, Wray D, Corey GR, Chu VH, International Collaboration on Endocarditis Prospective Cohort Study Investigators HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PLoS One 2013 8 e63181. doi: 10.1371/journal.pone.0063181
221. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernández-Hidalgo N, Dickerman S, Bouza E, del Río A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG Jr, International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med 2007 147 829 835
222. Reyes MP, Reyes KC, Gram-negative endocarditis. Curr Infect Dis Rep 2008 10 267 274
223. Hughes CF, Noble N, Vegetectomy: An alternative surgical treatment for infective endocarditis of the atrioventricular valves in drug addicts. J Thorac Cardiovasc Surg 1988 95 857 861
224. Arbulu A, Thoms NW, Chiscano A, Wilson RF, Total tricuspid valvulectomy without replacement in the treatment of Pseudomonas endocarditis. Surg Forum 1971 22 162 164
225. Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS, Infective endocarditis: An analysis based on strict case definitions. Ann Intern Med 1981 94 pt 1 505 518
226. Washington JA, The microbiological diagnosis of infective endocarditis. J Antimicrob Chemother 1987 20 suppl A 29 39
227. Werner AS, Cobbs CG, Kaye D, Hook EW, Studies on the bacteremia of bacterial endocarditis. JAMA 1967 202 199 203
228. Werner M, Andersson R, Olaison L, Hogevik H, A clinical study of culture-negative endocarditis. Medicine (Baltimore) 2003 82 263 273. doi: 10.1097/01.md.0000085056.63483.d2
229. Hoen B, Selton-Suty C, Lacassin F, Etienne J, Briançon S, Leport C, Canton P, Infective endocarditis in patients with negative blood cultures: Analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis 1995 20 501 506
230. Berbari EF, Cockerill FR 3rd, Steckelberg JM, Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc 1997 72 532 542. doi: 10.1016/S0025-6196(11)63302-8
231. Pazin GJ, Saul S, Thompson ME, Blood culture positivity: suppression by outpatient antibiotic therapy in patients with bacterial endocarditis. Arch Intern Med 1982 142 263 268
232. Tunkel AR, Kaye D, Endocarditis with negative blood cultures. N Engl J Med 1992 326 1215 1217. doi: 10.1056/NEJM199204303261809
233. Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS, A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis 2013 57 e22 e121. doi: 10.1093/cid/cit278
234. Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D, Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004 48 1921 1933. doi: 10.1128/AAC.48.6.1921-1933.2004
235. Thuny F, Fournier PE, Casalta JP, Gouriet F, Lepidi H, Riberi A, Collart F, Habib G, Raoult D, Investigation of blood culture-negative early prosthetic valve endocarditis reveals high prevalence of fungi. Heart 2010 96 743 747. doi: 10.1136/hrt.2009.181594
236. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D, Comprehensive diagnostic strategy for blood culture-negative endocarditis: A prospective study of 819 new cases. Clin Infect Dis 2010 51 131 140. doi: 10.1086/653675
237. Geissdörfer W, Moos V, Moter A, Loddenkemper C, Jansen A, Tandler R, Morguet AJ, Fenollar F, Raoult D, Bogdan C, Schneider T, High frequency of Tropheryma whipplei in culture-negative endocarditis. J Clin Microbiol 2012 50 216 222. doi: 10.1128/JCM.05531-11
238. Hojnik M, George J, Ziporen L, Shoenfeld Y, Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996 93 1579 1587
239. Kupferwasser LI, Hafner G, Mohr-Kahaly S, Erbel R, Meyer J, Darius H, The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events. J Am Coll Cardiol 1999 33 1365 1371
240. Pierrotti LC, Baddour LM, Fungal endocarditis, 1995-2000. Chest 2002 122 302 310
241. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W, Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 2001 32 50 62. doi: 10.1086/317550
242. Nguyen MH, Nguyen ML, Yu VL, McMahon D, Keys TF, Amidi M, Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. Clin Infect Dis 1996 22 262 267
243. Baddour LM, Infectious Diseases Society of America's Emerging Infections Network Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci 2001 322 209 212
244. Steinbach WJ, Perfect JR, Cabell CH, Fowler VG, Corey GR, Li JS, Zaas AK, Benjamin DK Jr, A meta-Analysis of medical versus surgical therapy for Candida endocarditis. J Infect 2005 51 230 247. doi: 10.1016/j.jinf.2004.10.016
245. Boland JM, Chung HH, Robberts FJ, Wilson WR, Steckelberg JM, Baddour LM, Miller DV, Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis. Mycoses 2011 54 354 360. doi: 10.1111/j.1439-0507.2010.01884.x
246. Smego RA Jr, Ahmad H, The role of fluconazole in the treatment of Candida endocarditis: A meta-Analysis. Medicine (Baltimore) 2011 90 237 249. doi: 10.1097/MD.0b013e3182259d38
247. Hoen B, Duval X, Clinical practice: infective endocarditis [published correction appears. N Engl J Med 2013 368 1425 1433. doi: 10.1056/NEJMcp1206782
248. Delahaye F, Is early surgery beneficial in infective endocarditis? A systematic review. Arch Cardiovasc Dis 2011 104 35 44. doi: 10.1016/j.acvd.2010.11.003
249. Tleyjeh IM, Kashour T, Zimmerman V, Steckelberg JM, Wilson WR, Baddour LM, The role of valve surgery in infective endocarditis management: A systematic review of observational studies that included propensity score analysis. Am Heart J 2008 156 901 909. doi: 10.1016/j.ahj.2008.06.031
250. Desch S, Freund A, de Waha S, Eitel I, Lurz P, Stiermaier T, Fuernau G, Schuler G, Thiele H, Outcome in patients with left-sided native-valve infective endocarditis and isolated large vegetations. Clin Cardiol 2014 37 626 633. doi: 10.1002/clc.22315
251. Chirouze C, Alla F, Fowler VG Jr, Sexton DJ, Corey GR, Chu VH, Wang A, Erpelding ML, Durante-Mangoni E, Fernández-Hidalgo N, Giannitsioti E, Hannan MM, Lejko-Zupanc T, Miró JM, Muñoz P, Murdoch DR, Tattevin P, Tribouilloy C, Hoen B, ICE Prospective Investigators Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: Analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. Clin Infect Dis 2015 60 741 749. doi: 10.1093/cid/ciu871
252. Karchmer AW, Bayer AS, Editorial commentary: surgical therapy for Staphylococcus aureus prosthetic valve endocarditis: proceed with caution (caveat emptor). Clin Infect Dis 2015 60 750 752. doi: 10.1093/cid/ciu877
253. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ, Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: A propensity analysis. JAMA 2003 290 3207 3214. doi: 10.1001/jama.290.24.3207
254. Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V, Fowler VG Jr, Woods CW, Engemann JJ, Corey GR, Harding T, Cabell CH, Early surgery in patients with infective endocarditis: A propensity score analysis. Clin Infect Dis 2007 44 364 372. doi: 10.1086/510583
255. Cabell CH, Abrutyn E, Fowler VG Jr, Hoen B, Miro JM, Corey GR, Olaison L, Pappas P, Anstrom KJ, Stafford JA, Eykyn S, Habib G, Mestres CA, Wang A, International Collaboration on Endocarditis Merged Database (ICE-MD) Study Group Investigators Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am Heart J 2005 150 1092 1098. doi: 10.1016/j.ahj.2005.03.057
256. Wang A, Pappas P, Anstrom KJ, Abrutyn E, Fowler VG Jr, Hoen B, Miro JM, Corey GR, Olaison L, Stafford JA, Mestres CA, Cabell CH, International Collaboration on Endocarditis Investigators The use and effect of surgical therapy for prosthetic valve infective endocarditis: A propensity analysis of a multicenter, international cohort. Am Heart J 2005 150 1086 1091. doi: 10.1016/j.ahj.2005.01.023
257. van Walraven C, Davis D, Forster AJ, Wells GA, Time-dependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol 2004 57 672 682. doi: 10.1016/j.jclinepi.2003.12.008
258. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Montori VM, Hoskin TL, Enders F, Huskins WC, Mookadam F, Wilson WR, Zimmerman V, Baddour LM, Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias. J Clin Epidemiol 2010 63 130 135. doi: 10.1016/j.jclinepi.2008.06.022
259. Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, Fowler VG Jr, Gordon D, Grossi P, Hannan M, Hoen B, Muñoz P, Rizk H, Kanj SS, Selton-Suty C, Sexton DJ, Spelman D, Ravasio V, Tripodi MF, Wang A, International Collaboration on Endocarditis-Prospective Cohort Study Investigators In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis [published correction appears in. JAMA Intern Med 2013 173 1495 1504. doi: 10.1001/jamainternmed.2013.8203
260. Gaca JG, Sheng S, Daneshmand MA, O'Brien S, Rankin JS, Brennan JM, Hughes GC, Glower DD, Gammie JS, Smith PK, Outcomes for endocarditis surgery in North America: A simplified risk scoring system. J Thorac Cardiovasc Surg 2011 141 98 106.e1 e2. doi: 10.1016/j.jtcvs.2010.09.016
261. Botelho-Nevers E, Thuny F, Casalta JP, Richet H, Gouriet F, Collart F, Riberi A, Habib G, Raoult D, Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009 169 1290 1298. doi: 10.1001/archinternmed.2009.192
262. Tleyjeh IM, Steckelberg JM, Georgescu G, Ghomrawi HM, Hoskin TL, Enders FB, Mookadam F, Huskins WC, Wilson WR, Baddour LM, The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis [published correction appears in. Heart 2008 94 892 896. doi: 10.1136/hrt.2007.118968
263. Musci M, Siniawski H, Pasic M, Grauhan O, Weng Y, Meyer R, Yankah CA, Hetzer R, Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience. Eur J Cardiothorac Surg 2007 32 118 125. doi: 10.1016/j.ejcts.2007.02.034
264. Akinosoglou K, Apostolakis E, Koutsogiannis N, Leivaditis V, Gogos CA, Right-sided infective endocarditis: surgical management. Eur J Cardiothorac Surg 2012 42 470 479. doi: 10.1093/ejcts/ezs084
265. Maruyama M, Kuriyama Y, Sawada T, Yamaguchi T, Fujita T, Omae T, Brain damage after open heart surgery in patients with acute cardioembolic stroke. Stroke 1989 20 1305 1310
266. Gillinov AM, Shah RV, Curtis WE, Stuart RS, Cameron DE, Baumgartner WA, Greene PS, Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg 1996 61 1125 1129
267. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T, Surgical management of infective endocarditis associated with cerebral complications: multi-center retrospective study in Japan. J Thorac Cardiovasc Surg 1995 110 1745 1755
268. Cooper HA, Thompson EC, Laureno R, Fuisz A, Mark AS, Lin M, Goldstein SA, Subclinical brain embolization in left-sided infective endocarditis: results from the Evaluation by MRI of the Brains of Patients With Left-Sided Intracardiac Solid Masses (EMBOLISM) pilot study. Circulation 2009 120 585 591. doi: 10.1161/CIRCULATIONAHA.108.834432
269. Hosono M, Sasaki Y, Hirai H, Sakaguchi M, Nakahira A, Seo H, Morisaki A, Suehiro S, Considerations in timing of surgical intervention for infective endocarditis with cerebrovascular complications. J Heart Valve Dis 2010 19 321 325
270. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC, Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 2006 37 2094 2099. doi: 10.1161/01.STR.0000229894.28591.3f
271. Snygg-Martin U, Gustafsson L, Rosengren L, Alsiö A, Ackerholm P, Andersson R, Olaison L, Cerebrovascular complications in patients with left-sided infective endocarditis are common: A prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 2008 47 23 30. doi: 10.1086/588663
272. Thuny F, Avierinos JF, Tribouilloy C, Giorgi R, Casalta JP, Milandre L, Brahim A, Nadji G, Riberi A, Collart F, Renard S, Raoult D, Habib G, Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: A prospective multicentre study. Eur Heart J 2007 28 1155 1161. doi: 10.1093/eurheartj/ehm005
273. Barsic B, Dickerman S, Krajinovic V, Pappas P, Altclas J, Carosi G, Casabé JH, Chu VH, Delahaye F, Edathodu J, Fortes CQ, Olaison L, Pangercic A, Patel M, Rudez I, Tamin SS, Vincelj J, Bayer AS, Wang A, International Collaboration on Endocarditis-Prospective Cohort Study Investigators Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis 2013 56 209 217. doi: 10.1093/cid/cis878
274. García-Cabrera E, Fernández-Hidalgo N, Almirante B, Ivanova-Georgieva R, Noureddine M, Plata A, Lomas JM, Gálvez-Acebal J, Hidalgo-Tenorio C, Ruíz-Morales J, Martínez-Marcos FJ, Reguera JM, de la Torre-Lima J, de Alarcón González A, Group for the Study of Cardiovascular Infections of the Andalusian Society of Infectious Diseases; Spanish Network for Research in Infectious Diseases Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: A multicenter observational study. Circulation 2013 127 2272 2284. doi: 10.1161/CIRCULATIONAHA.112.000813
275. Lutas EM, Roberts RB, Devereux RB, Prieto LM, Relation between the presence of echocardiographic vegetations and the complication rate in infective endocarditis. Am Heart J 1986 112 107 113
276. De Castro S, Magni G, Beni S, Cartoni D, Fiorelli M, Venditti M, Schwartz SL, Fedele F, Pandian NG, Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. Am J Cardiol 1997 80 1030 1034
277. Heiro M, Nikoskelainen J, Engblom E, Kotilainen E, Marttila R, Kotilainen P, Neurologic manifestations of infective endocarditis: A 17-year experience in a teaching hospital in Finland. Arch Intern Med 2000 160 2781 2787
278. Vilacosta I, Graupner C, San Román JA, Sarriá C, Ronderos R, Fernández C, Mancini L, Sanz O, Sanmartín JV, Stoermann W, Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002 39 1489 1495
279. Dickerman SA, Abrutyn E, Barsic B, Bouza E, Cecchi E, Moreno A, Doco-Lecompte T, Eisen DP, Fortes CQ, Fowler VG Jr, Lerakis S, Miro JM, Pappas P, Peterson GE, Rubinstein E, Sexton DJ, Suter F, Tornos P, Verhagen DW, Cabell CH, ICE Investigators The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 2007 154 1086 1094. doi: 10.1016/j.ahj.2007.07.023
280. Thuny F, Di Salvo G, Belliard O, Avierinos JF, Pergola V, Rosenberg V, Casalta JP, Gouvernet J, Derumeaux G, Iarussi D, Ambrosi P, Calabró R, Calabro R, Riberi A, Collart F, Metras D, Lepidi H, Raoult D, Harle JR, Weiller PJ, Cohen A, Habib G, Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: A prospective multicenter study [published correction appears in Circulation. 2005;112:e125]. Circulation 2005 112 69 75. doi: 10.1161/CIRCULATIONAHA.104.493155
281. Alsip SG, Blackstone EH, Kirklin JW, Cobbs CG, Indications for cardiac surgery in patients with active infective endocarditis. Am J Med 1985 78 138 148
282. Di Salvo G, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP, Vailloud JM, Derumeaux G, Gouvernet J, Ambrosi P, Lambert M, Ferracci A, Raoult D, Luccioni R, Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001 37 1069 1076
283. Chu VH, Cabell CH, Benjamin DK Jr, Kuniholm EF, Fowler VG Jr, Engemann J, Sexton DJ, Corey GR, Wang A, Early predictors of in-hospital death in infective endocarditis. Circulation 2004 109 1745 1749. doi: 10.1161/01.CIR.0000124719.61827.7F
284. Salem DN, Daudelin HD, Levine HJ, Pauker SG, Eckman MH, Riff J, Antithrombotic therapy in valvular heart disease. Chest 2001 119 suppl 207S 219S
285. Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J, Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med 1999 159 473 475
286. Kupferwasser LI, Yeaman MR, Nast CC, Kupferwasser D, Xiong YQ, Palma M, Cheung AL, Bayer AS, Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest 2003 112 222 233. doi: 10.1172/JCI16876
287. Chan KL, Dumesnil JG, Cujec B, Sanfilippo AJ, Jue J, Turek MA, Robinson TI, Moher D, Investigators of the Multicenter Aspirin Study in Infective Endocarditis A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003 42 775 780
288. Kupferwasser LI, Yeaman MR, Shapiro SM, Nast CC, Sullam PM, Filler SG, Bayer AS, Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 1999 99 2791 2797
289. Anavekar NS, Tleyjeh IM, Anavekar NS, Mirzoyev Z, Steckelberg JM, Haddad C, Khandaker MH, Wilson WR, Chandrasekaran K, Baddour LM, Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis [published correction appears in Clin Infect Dis. 2007;44:1398] 1180 1186. doi: 10.1086/513197
290. Chan KL, Tam J, Dumesnil JG, Cujec B, Sanfilippo AJ, Jue J, Turek M, Robinson T, Williams K, Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis 2008 46 37 41. doi: 10.1086/524021
291. Eisen DP, Corey GR, McBryde ES, Fowler VG Jr, Miro JM, Cabell CH, Street AC, Paiva MG, Ionac A, Tan RS, Tribouilloy C, Pachirat O, Jones SB, Chipigina N, Naber C, Pan A, Ravasio V, Gattringer R, Chu VH, Bayer AS, ICE Investigators Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid. J Infect 2009 58 332 338. doi: 10.1016/j.jinf.2009.03.006
292. Pepin J, Tremblay V, Bechard D, Rodier F, Walker C, Dufresne D, Lafontaine A, Li N, Lacroix C, Lanthier L, Chronic antiplatelet therapy and mortality among patients with infective endocarditis. Clin Microbiol Infect 2009 15 193 199. doi: 10.1111/j.1469-0691.2008.02665.x
293. Snygg-Martin U, Rasmussen RV, Hassager C, Bruun NE, Andersson R, Olaison L, The relationship between cerebrovascular complications and previously established use of antiplatelet therapy in left-sided infective endocarditis. Scand J Infect Dis 2011 43 899 904. doi: 10.3109/00365548.2011.603742
294. Anavekar NS, Schultz JC, De Sa DD, Thomas JM, Lahr BD, Tleyjeh IM, Steckelberg JM, Wilson WR, Baddour LM, Modifiers of symptomatic embolic risk in infective endocarditis [published correction appears in. Mayo Clin Proc 2011 86 1068 1074. doi: 10.4065/mcp.2011.0111
295. Omari B, Shapiro S, Ginzton L, Robertson JM, Ward J, Nelson RJ, Bayer AS, Predictive risk factors for periannular extension of native valve endocarditis: clinical and echocardiographic analyses. Chest 1989 96 1273 1279
296. Middlemost S, Wisenbaugh T, Meyerowitz C, Teeger S, Essop R, Skoularigis J, Cronje S, Sareli P, A case for early surgery in native left-sided endocarditis complicated by heart failure: results in 203 patients. J Am Coll Cardiol 1991 18 663 667
297. Blumberg EA, Karalis DA, Chandrasekaran K, Wahl JM, Vilaro J, Covalesky VA, Mintz GS, Endocarditis-Associated paravalvular abscesses: do clinical parameters predict the presence of abscess? Chest 1995 107 898 903
298. Becher H, Hanrath P, Bleifeld W, Bleese N, Correlation of echocardiographic and surgical findings in acute bacterial endocarditis. Eur Heart J 1984 5 suppl C 67 70
299. Arnett EN, Roberts WC, Prosthetic valve endocarditis: clinicopathologic analysis of 22 necropsy patients with comparison observations in 74 necropsy patients with active infective endocarditis involving natural left-sided cardiac valves. Am J Cardiol 1976 38 281 292
300. Fernicola DJ, Roberts WC, Frequency of ring abscess and cuspal infection in active infective endocarditis involving bioprosthetic valves. Am J Cardiol 1993 72 314 323
301. Carpenter JL, Perivalvular extension of infection in patients with infectious endocarditis. Rev Infect Dis 1991 13 127 138
302. Anguera I, Miro JM, Vilacosta I, Almirante B, Anguita M, Muñoz P, Roman JA, de Alarcon A, Ripoll T, Navas E, Gonzalez-Juanatey C, Cabell CH, Sarria C, Garcia-Bolao I, Fariñas MC, Leta R, Rufi G, Miralles F, Pare C, Evangelista A, Fowler VG Jr, Mestres CA, de Lazzari E, Guma JR, Aorto-cavitary Fistula in Endocarditis Working Group Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J 2005 26 288 297. doi: 10.1093/eurheartj/ehi034
303. Daniel W, Schroder E, Nonast-Daniel B, Lichtlen P, Conventional and transoesophageal echocardiography in the diagnosis of infective endocarditis. Eur Heart J 1987 8 287 292
304. Leung DY, Cranney GB, Hopkins AP, Walsh WF, Role of transoesophageal echocardiography in the diagnosis and management of aortic root abscess. Br Heart J 1994 72 175 181
305. Rohmann S, Seifert T, Erbel R, Jakob H, Mohr-Kahaly S, Makowski T, Görge G, Oelert H, Meyer J, Identification of abscess formation in native-valve infective endocarditis using transesophageal echocardiography: implications for surgical treatment. Thorac Cardiovasc Surg 1991 39 273 280. doi: 10.1055/s-2007-1019985
306. Kunis RL, Sherrid MV, McCabe JB, Grieco MH, Dwyer EM Jr, Successful medical therapy of mitral anular abscess complicating infective endocarditis. J Am Coll Cardiol 1986 7 953 955
307. Vlessis AA, Hovaguimian H, Jaggers J, Ahmad A, Starr A, Infective endocarditis: ten-year review of medical and surgical therapy. Ann Thorac Surg 1996 61 1217 1222
308. Mullany CJ, Chua YL, Schaff HV, Steckelberg JM, Ilstrup DM, Orszulak TA, Danielson GK, Puga FJ, Early and late survival after surgical treatment of culture-positive active endocarditis. Mayo Clin Proc 1995 70 517 525. doi: 10.1016/S0025-6196(11)64307-3
309. Glazier JJ, Verwilghen J, Donaldson RM, Ross DN, Treatment of complicated prosthetic aortic valve endocarditis with annular abscess formation by homograft aortic root replacement. J Am Coll Cardiol 1991 17 1177 1182
310. Ross D, Allograft root replacement for prosthetic endocarditis. J Card Surg 1990 5 68 72
311. McGiffin DC, Galbraith AJ, McLachlan GJ, Stower RE, Wong ML, Stafford EG, Gardner MA, Pohlner PG, O'Brien MF, Aortic valve infection: risk factors for death and recurrent endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg 1992 104 511 520
312. Walkes JC, Reardon MJ, Current thinking in stentless valve surgery. Curr Opin Cardiol 2003 18 117 123
313. Chun CH, Raff MJ, Contreras L, Varghese R, Waterman N, Daffner R, Melo JC, Splenic abscess. Medicine (Baltimore) 1980 59 50 65
314. Bohmfalk GL, Story JL, Wissinger JP, Brown WE Jr, Bacterial intracranial aneurysm. J Neurosurg 1978 48 369 382
315. Wilson WR, Giuliani ER, Danielson GK, Geraci JE, Management of complications of infective endocarditis. Mayo Clin Proc 1982 57 162 170
316. Camarata PJ, Latchaw RE, Rüfenacht DA, Heros RC, Intracranial aneurysms. Invest Radiol 1993 28 373 382
317. Lerner PI, Neurologic complications of infective endocarditis. Med Clin North Am 1985 69 385 398
318. Clare CE, Barrow DL, Infectious intracranial aneurysms. Neurosurg Clin N Am 1992 3 551 566
319. Moskowitz MA, Rosenbaum AE, Tyler HR, Angiographically monitored resolution of cerebral mycotic aneurysms. Neurology 1974 24 1103 1108
320. Huston J 3rd, Nichols DA, Luetmer PH, Goodwin JT, Meyer FB, Wiebers DO, Weaver AL, Blinded prospective evaluation of sensitivity of MR angiography to known intracranial aneurysms: importance of aneurysm size. AJNR Am J Neuroradiol 1994 15 1607 1614
321. Wilson WR, Bower TC, Creager MA, Amin-Hanjani S, O'Gara PT, Lockhart PB, Darouiche RO, Ramlawi B, Derdeyn CP, Bolger AF, Levison ME, Taubert KA, Baltimore RS, Baddour LM; on behalf of the American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular Surgery and Anesthesia, Council on Peripheral Vascular Disease, and Stroke Council, Vascular graft infections, mycotic aneurysms, and endovascular infections: A scientific statement from the American Heart Association. Circulation. In press
322. Tice AD, Safety of outpatient parenteral antimicrobial therapy for endocarditis. Clin Infect Dis 2002 34 419 420. doi: 10.1086/324369
323. Monteiro CA, Cobbs CG, Outpatient management of infective endocarditis. Curr Infect Dis Rep 2001 3 319 327
324. Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, Gainer RB, Kunkel MJ, Yancey RW, Williams DN, IDSA Practice guidelines for outpatient parenteral antimicrobial therapy: IDSA guidelines. Clin Infect Dis 2004 38 1651 1672. doi: 10.1086/420939
325. Andrews MM, von Reyn CF, Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis. Clin Infect Dis 2001 33 203 209. doi: 10.1086/321814
326. Lockhart PB, Brennan MT, Thornhill M, Michalowicz BS, Noll J, Bahrani-Mougeot FK, Sasser HC, Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J Am Dent Assoc 2009 140 1238 1244
327. Lockhart PB, Antibiotic prophylaxis for dental procedures: Are we drilling in the wrong direction? Circulation 2012 126 11 12. doi: 10.1161/CIRCULATIONAHA.112.115204